Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BORDEN

Showing results (291-300 of 327) with videos related to

Pageof 33
Sort By:
Cancer Research|August 25, 1991
Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferonsJ W Greiner, F Guadagni, D Goldstein, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1993
Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-betaP L Witt, B E Storer, G T Bryan, et al.
Journal of Interferon Research|December 1, 1992
Phase II trials of interferons-alpha and -beta in advanced sarcomasE C Borden, K Kim, L Ryan, et al.
Cancer Clinical Trials|January 1, 1981
Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomasN E Mischler, D C Tormey, J Klotz, et al.
Journal of Interferon Research|October 1, 1993
Effects of cytokines on the pituitary-adrenal axis in cancer patientsW E Nolten, D Goldstein, M Lindstrom, et al.
Seminars in Hematology|October 1, 1994
Retinoic acid and interferon in human cancer: mechanistic and clinical studiesD M Moore, D V Kalvakolanu, S M Lippman, et al.
Investigational New Drugs|January 1, 1987
Effect of interferon alpha, interferon beta, and interferon gamma on the in vitro growth of human renal adenocarcinoma cellsJ P Kuebler, T D Oberley, L F Meisner, et al.
Journal of the National Cancer Institute|April 5, 1989
Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cellsF Guadagni, J Schlom, W W Johnston, et al.
Investigational New Drugs|January 1, 1985
Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesotheliomaD A Amato, E C Borden, M Shiraki, et al.
Investigational New Drugs|February 1, 1990
Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomasR H Earhart, D J Amato, A Y Chang, et al.
Pageof 33

Showing results (291-300 of 327) with videos related to

Sort By:
Pageof 33
Cancer Research|August 25, 1991
Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferonsJ W Greiner, F Guadagni, D Goldstein, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1993
Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-betaP L Witt, B E Storer, G T Bryan, et al.
Journal of Interferon Research|December 1, 1992
Phase II trials of interferons-alpha and -beta in advanced sarcomasE C Borden, K Kim, L Ryan, et al.
Cancer Clinical Trials|January 1, 1981
Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomasN E Mischler, D C Tormey, J Klotz, et al.
Journal of Interferon Research|October 1, 1993
Effects of cytokines on the pituitary-adrenal axis in cancer patientsW E Nolten, D Goldstein, M Lindstrom, et al.
Seminars in Hematology|October 1, 1994
Retinoic acid and interferon in human cancer: mechanistic and clinical studiesD M Moore, D V Kalvakolanu, S M Lippman, et al.
Investigational New Drugs|January 1, 1987
Effect of interferon alpha, interferon beta, and interferon gamma on the in vitro growth of human renal adenocarcinoma cellsJ P Kuebler, T D Oberley, L F Meisner, et al.
Journal of the National Cancer Institute|April 5, 1989
Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cellsF Guadagni, J Schlom, W W Johnston, et al.
Investigational New Drugs|January 1, 1985
Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesotheliomaD A Amato, E C Borden, M Shiraki, et al.
Investigational New Drugs|February 1, 1990
Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomasR H Earhart, D J Amato, A Y Chang, et al.
Pageof 33